Preload Image
Preload Image
Report Store mobile icon
Global Drug Allergy Treatments and Drugs Market Growth 2024-2030

Global Drug Allergy Treatments and Drugs Market Growth 2024-2030

2024

Global Drug Allergy Treatments and Drugs Market Growth 2024-2030

The global Drug Allergy Treatments and Drugs market was valued at US$ 76.31 billion in 2023, with growing demand for allergy management and treatment options.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global drug allergy treatments and drugs market is a rapidly expanding sector within the pharmaceutical industry, driven by the increasing prevalence of allergic reactions and the growing demand for effective treatments. This market encompasses a wide range of products, including antihistamines, corticosteroids, decongestants, immunotherapy, and biologics, designed to manage and reduce allergic symptoms. The rising incidence of allergies, such as allergic rhinitis, asthma, food allergies, and atopic dermatitis, is a significant driver of market growth. Environmental factors, lifestyle changes, and genetic predispositions contribute to the increasing number of individuals affected by allergies, necessitating advanced treatment options3. Technological advancements in drug development and personalized medicine are enhancing treatment effectiveness and patient outcomes. The market is also benefiting from increased awareness of allergies and their impact on health, leading to higher demand for innovative and improved treatment alternatives. The global Drug Allergy Treatments and Drugs market is poised for continued growth, supported by ongoing research and development efforts, regulatory approvals, and the introduction of new therapeutic options.

According to Publisher, the global Drug Allergy Treatments and Drugs market size was valued at US$ 76310 million in 2023. With growing demand in downstream market, the Drug Allergy Treatments and Drugs is forecast to a readjusted size of US$ 99330 million by 2030 with a CAGR of 3.8% during review period. The global drug allergy treatments and drugs market is driven by several key factors, including the increasing prevalence of allergic diseases, environmental factors, lifestyle changes, and advancements in drug development. Allergic conditions such as asthma, allergic rhinitis, food allergies, and atopic dermatitis are becoming more common, leading to a higher demand for effective treatments. Environmental factors like pollution and climate change contribute to the rising incidence of allergies, necessitating advanced therapeutic options2. Lifestyle changes, including dietary habits and increased exposure to allergens, also play a significant role in the growing prevalence of allergic reactions. Technological advancements in drug development, such as the introduction of biologics and personalized medicine, are enhancing treatment effectiveness and patient outcomes. Additionally, increased awareness of allergies and their impact on health is driving the demand for innovative and improved treatment alternatives. These factors collectively contribute to the steady growth of the global Drug Allergy Treatments and Drugs market, making it a vital segment within the pharmaceutical industry. The research report highlights the growth potential of the global Drug Allergy Treatments and Drugs market. Drug Allergy Treatments and Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Allergy Treatments and Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Allergy Treatments and Drugs market.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global Drug Allergy Treatments and Drugs market is segmented by type into anti-allergy drugs and immunotherapy. Anti-allergy drugs include antihistamines, corticosteroids, decongestants, and other drugs. Antihistamines are commonly used to alleviate symptoms such as sneezing, itching, and runny nose by blocking histamine receptors. Corticosteroids are potent anti-inflammatory agents that help reduce swelling and allergic reactions. Decongestants relieve nasal congestion by narrowing blood vessels in the nasal passages. Other drugs may include leukotriene modifiers and mast cell stabilizers, which are used to manage specific allergic conditions. Immunotherapy involves subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). SCIT involves injecting small doses of allergens under the skin to build tolerance over time, while SLIT involves placing allergen extracts under the tongue. These treatments aim to desensitize the immune system to allergens, providing long-term relief from allergic symptoms. Each type of treatment plays a crucial role in managing and reducing allergic reactions, contributing to the overall growth and innovation in the global drug allergy treatments and drugs market.

The global drug allergy treatments and drugs market is segmented by application into eye allergy treatments, rhinitis treatments, asthma treatments, skin allergy treatments, food allergy treatments, and other allergy treatments. Eye allergy treatments focus on alleviating symptoms such as itching, redness, and tearing caused by allergens like pollen, dust, and pet dander. Rhinitis treatments aim to manage nasal congestion, sneezing, and runny nose associated with allergic rhinitis. Asthma treatments are designed to control and prevent asthma attacks triggered by allergens, using medications like inhalers and nebulizers. Skin allergy treatments address conditions like eczema and hives, providing relief from itching and inflammation. Food allergy treatments involve managing allergic reactions to specific foods, often through avoidance and emergency medications like epinephrine. The "Other Allergy Treatments" category includes therapies for less common allergic conditions and emerging treatments. Each application segment addresses specific allergic conditions, driving innovation and growth in the global drug allergy treatments and drugs market.

The regional analysis of the global drug allergy treatments and drugs market reveals distinct trends and growth patterns across different geographical areas. The North American region holds a dominant position, driven by a well-established healthcare infrastructure, high demand for advanced allergy treatments, and significant government spending on healthcare. The region is home to leading pharmaceutical companies that frequently introduce new allergy treatments, ensuring patients have access to the latest options. Europe follows closely, with countries like Germany, the UK, and France leading in the adoption of innovative allergy treatments. The Asia-Pacific region is experiencing rapid growth, fueled by improving healthcare infrastructure, rising disposable incomes, and increasing awareness of allergies. Countries like China and India are major contributors to this growth, supported by local manufacturers and international players expanding their presence in these markets. The Latin American region is also witnessing steady growth, driven by improving healthcare systems and rising demand for allergy treatments. The Middle East and Africa regions are emerging markets, with increasing investments in healthcare infrastructure and a growing focus on improving the quality of care. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global drug allergy treatments and drugs market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Drug Allergy Treatments and Drugs Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Drug Allergy Treatments and Drugs by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Drug Allergy Treatments and Drugs by Country/Region, 2019, 2023 & 2030
  • 2.2 Drug Allergy Treatments and Drugs Segment by Type
  • 2.2.1 Penicillin and Related Drugs
  • 2.2.2 Sulfa Drugs
  • 2.2.3 Insulin
  • 2.2.4 Iodine
  • 2.2.5 Chemotherapy Drugs
  • 2.2.6 Other
  • 2.3 Drug Allergy Treatments and Drugs Sales by Type
  • 2.3.1 Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Drug Allergy Treatments and Drugs Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Drug Allergy Treatments and Drugs Sale Price by Type (2019-2024)
  • 2.4 Drug Allergy Treatments and Drugs Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Diagnostic Laboratories
  • 2.4.3 Research & Academic Laboratories
  • 2.4.4 Pharmaceutical & Biotechnology Companies
  • 2.5 Drug Allergy Treatments and Drugs Sales by Application
  • 2.5.1 Global Drug Allergy Treatments and Drugs Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Drug Allergy Treatments and Drugs Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Drug Allergy Treatments and Drugs Sale Price by Application (2019-2024)
  • 3 Global Drug Allergy Treatments and Drugs by Company
  • 3.1 Global Drug Allergy Treatments and Drugs Breakdown Data by Company
  • 3.1.1 Global Drug Allergy Treatments and Drugs Annual Sales by Company (2019-2024)
  • 3.1.2 Global Drug Allergy Treatments and Drugs Sales Market Share by Company (2019-2024)
  • 3.2 Global Drug Allergy Treatments and Drugs Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Drug Allergy Treatments and Drugs Revenue by Company (2019-2024)
  • 3.2.2 Global Drug Allergy Treatments and Drugs Revenue Market Share by Company (2019-2024)
  • 3.3 Global Drug Allergy Treatments and Drugs Sale Price by Company
  • 3.4 Key Manufacturers Drug Allergy Treatments and Drugs Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Drug Allergy Treatments and Drugs Product Location Distribution
  • 3.4.2 Players Drug Allergy Treatments and Drugs Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Drug Allergy Treatments and Drugs by Geographic Region
  • 4.1 World Historic Drug Allergy Treatments and Drugs Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Drug Allergy Treatments and Drugs Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Drug Allergy Treatments and Drugs Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Drug Allergy Treatments and Drugs Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Drug Allergy Treatments and Drugs Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Drug Allergy Treatments and Drugs Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Drug Allergy Treatments and Drugs Sales Growth
  • 4.4 APAC Drug Allergy Treatments and Drugs Sales Growth
  • 4.5 Europe Drug Allergy Treatments and Drugs Sales Growth
  • 4.6 Middle East & Africa Drug Allergy Treatments and Drugs Sales Growth
  • 5 Americas
  • 5.1 Americas Drug Allergy Treatments and Drugs Sales by Country
  • 5.1.1 Americas Drug Allergy Treatments and Drugs Sales by Country (2019-2024)
  • 5.1.2 Americas Drug Allergy Treatments and Drugs Revenue by Country (2019-2024)
  • 5.2 Americas Drug Allergy Treatments and Drugs Sales by Type
  • 5.3 Americas Drug Allergy Treatments and Drugs Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Drug Allergy Treatments and Drugs Sales by Region
  • 6.1.1 APAC Drug Allergy Treatments and Drugs Sales by Region (2019-2024)
  • 6.1.2 APAC Drug Allergy Treatments and Drugs Revenue by Region (2019-2024)
  • 6.2 APAC Drug Allergy Treatments and Drugs Sales by Type
  • 6.3 APAC Drug Allergy Treatments and Drugs Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Drug Allergy Treatments and Drugs by Country
  • 7.1.1 Europe Drug Allergy Treatments and Drugs Sales by Country (2019-2024)
  • 7.1.2 Europe Drug Allergy Treatments and Drugs Revenue by Country (2019-2024)
  • 7.2 Europe Drug Allergy Treatments and Drugs Sales by Type
  • 7.3 Europe Drug Allergy Treatments and Drugs Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Drug Allergy Treatments and Drugs by Country
  • 8.1.1 Middle East & Africa Drug Allergy Treatments and Drugs Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Drug Allergy Treatments and Drugs Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Drug Allergy Treatments and Drugs Sales by Type
  • 8.3 Middle East & Africa Drug Allergy Treatments and Drugs Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Drug Allergy Treatments and Drugs
  • 10.3 Manufacturing Process Analysis of Drug Allergy Treatments and Drugs
  • 10.4 Industry Chain Structure of Drug Allergy Treatments and Drugs
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Drug Allergy Treatments and Drugs Distributors
  • 11.3 Drug Allergy Treatments and Drugs Customer
  • 12 World Forecast Review for Drug Allergy Treatments and Drugs by Geographic Region
  • 12.1 Global Drug Allergy Treatments and Drugs Market Size Forecast by Region
  • 12.1.1 Global Drug Allergy Treatments and Drugs Forecast by Region (2025-2030)
  • 12.1.2 Global Drug Allergy Treatments and Drugs Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Drug Allergy Treatments and Drugs Forecast by Type
  • 12.7 Global Drug Allergy Treatments and Drugs Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Stallergenes Greer
  • 13.1.1 Stallergenes Greer Company Information
  • 13.1.2 Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.1.3 Stallergenes Greer Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Stallergenes Greer Main Business Overview
  • 13.1.5 Stallergenes Greer Latest Developments
  • 13.2 Allergy Therapeutics
  • 13.2.1 Allergy Therapeutics Company Information
  • 13.2.2 Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.2.3 Allergy Therapeutics Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Allergy Therapeutics Main Business Overview
  • 13.2.5 Allergy Therapeutics Latest Developments
  • 13.3 HAL Allergy Group
  • 13.3.1 HAL Allergy Group Company Information
  • 13.3.2 HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.3.3 HAL Allergy Group Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 HAL Allergy Group Main Business Overview
  • 13.3.5 HAL Allergy Group Latest Developments
  • 13.4 Circassia
  • 13.4.1 Circassia Company Information
  • 13.4.2 Circassia Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.4.3 Circassia Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Circassia Main Business Overview
  • 13.4.5 Circassia Latest Developments
  • 13.5 GlaxoSmithKline plc
  • 13.5.1 GlaxoSmithKline plc Company Information
  • 13.5.2 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.5.3 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 GlaxoSmithKline plc Main Business Overview
  • 13.5.5 GlaxoSmithKline plc Latest Developments
  • 13.6 Sunovion Pharmaceuticals
  • 13.6.1 Sunovion Pharmaceuticals Company Information
  • 13.6.2 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.6.3 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Sunovion Pharmaceuticals Main Business Overview
  • 13.6.5 Sunovion Pharmaceuticals Latest Developments
  • 13.7 Teva Pharmaceutical Industries
  • 13.7.1 Teva Pharmaceutical Industries Company Information
  • 13.7.2 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.7.3 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Teva Pharmaceutical Industries Main Business Overview
  • 13.7.5 Teva Pharmaceutical Industries Latest Developments
  • 13.8 Allergan plc
  • 13.8.1 Allergan plc Company Information
  • 13.8.2 Allergan plc Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.8.3 Allergan plc Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Allergan plc Main Business Overview
  • 13.8.5 Allergan plc Latest Developments
  • 13.9 Mayo Clinic
  • 13.9.1 Mayo Clinic Company Information
  • 13.9.2 Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.9.3 Mayo Clinic Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Mayo Clinic Main Business Overview
  • 13.9.5 Mayo Clinic Latest Developments
  • 13.10 AAFA
  • 13.10.1 AAFA Company Information
  • 13.10.2 AAFA Drug Allergy Treatments and Drugs Product Portfolios and Specifications
  • 13.10.3 AAFA Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 AAFA Main Business Overview
  • 13.10.5 AAFA Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Drug Allergy Treatments and Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Drug Allergy Treatments and Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Penicillin and Related Drugs
Table 4. Major Players of Sulfa Drugs
Table 5. Major Players of Insulin
Table 6. Major Players of Iodine
Table 7. Major Players of Chemotherapy Drugs
Table 8. Major Players of Other
Table 9. Global Drug Allergy Treatments and Drugs Sales by Type (2019-2024) & (K Units)
Table 10. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
Table 11. Global Drug Allergy Treatments and Drugs Revenue by Type (2019-2024) & ($ million)
Table 12. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2019-2024)
Table 13. Global Drug Allergy Treatments and Drugs Sale Price by Type (2019-2024) & (USD/Unit)
Table 14. Global Drug Allergy Treatments and Drugs Sales by Application (2019-2024) & (K Units)
Table 15. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2019-2024)
Table 16. Global Drug Allergy Treatments and Drugs Revenue by Application (2019-2024)
Table 17. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2019-2024)
Table 18. Global Drug Allergy Treatments and Drugs Sale Price by Application (2019-2024) & (USD/Unit)
Table 19. Global Drug Allergy Treatments and Drugs Sales by Company (2019-2024) & (K Units)
Table 20. Global Drug Allergy Treatments and Drugs Sales Market Share by Company (2019-2024)
Table 21. Global Drug Allergy Treatments and Drugs Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Drug Allergy Treatments and Drugs Revenue Market Share by Company (2019-2024)
Table 23. Global Drug Allergy Treatments and Drugs Sale Price by Company (2019-2024) & (USD/Unit)
Table 24. Key Manufacturers Drug Allergy Treatments and Drugs Producing Area Distribution and Sales Area
Table 25. Players Drug Allergy Treatments and Drugs Products Offered
Table 26. Drug Allergy Treatments and Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Drug Allergy Treatments and Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Drug Allergy Treatments and Drugs Sales Market Share Geographic Region (2019-2024)
Table 31. Global Drug Allergy Treatments and Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Drug Allergy Treatments and Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Drug Allergy Treatments and Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Drug Allergy Treatments and Drugs Sales Market Share by Country/Region (2019-2024)
Table 35. Global Drug Allergy Treatments and Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Drug Allergy Treatments and Drugs Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Drug Allergy Treatments and Drugs Sales by Country (2019-2024) & (K Units)
Table 38. Americas Drug Allergy Treatments and Drugs Sales Market Share by Country (2019-2024)
Table 39. Americas Drug Allergy Treatments and Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Drug Allergy Treatments and Drugs Revenue Market Share by Country (2019-2024)
Table 41. Americas Drug Allergy Treatments and Drugs Sales by Type (2019-2024) & (K Units)
Table 42. Americas Drug Allergy Treatments and Drugs Sales by Application (2019-2024) & (K Units)
Table 43. APAC Drug Allergy Treatments and Drugs Sales by Region (2019-2024) & (K Units)
Table 44. APAC Drug Allergy Treatments and Drugs Sales Market Share by Region (2019-2024)
Table 45. APAC Drug Allergy Treatments and Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Drug Allergy Treatments and Drugs Revenue Market Share by Region (2019-2024)
Table 47. APAC Drug Allergy Treatments and Drugs Sales by Type (2019-2024) & (K Units)
Table 48. APAC Drug Allergy Treatments and Drugs Sales by Application (2019-2024) & (K Units)
Table 49. Europe Drug Allergy Treatments and Drugs Sales by Country (2019-2024) & (K Units)
Table 50. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country (2019-2024)
Table 51. Europe Drug Allergy Treatments and Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Drug Allergy Treatments and Drugs Revenue Market Share by Country (2019-2024)
Table 53. Europe Drug Allergy Treatments and Drugs Sales by Type (2019-2024) & (K Units)
Table 54. Europe Drug Allergy Treatments and Drugs Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Drug Allergy Treatments and Drugs Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Drug Allergy Treatments and Drugs Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Drug Allergy Treatments and Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Drug Allergy Treatments and Drugs Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Drug Allergy Treatments and Drugs Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Drug Allergy Treatments and Drugs Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Drug Allergy Treatments and Drugs
Table 62. Key Market Challenges & Risks of Drug Allergy Treatments and Drugs
Table 63. Key Industry Trends of Drug Allergy Treatments and Drugs
Table 64. Drug Allergy Treatments and Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Drug Allergy Treatments and Drugs Distributors List
Table 67. Drug Allergy Treatments and Drugs Customer List
Table 68. Global Drug Allergy Treatments and Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Drug Allergy Treatments and Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Drug Allergy Treatments and Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Drug Allergy Treatments and Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Drug Allergy Treatments and Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Drug Allergy Treatments and Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Drug Allergy Treatments and Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Drug Allergy Treatments and Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Drug Allergy Treatments and Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Drug Allergy Treatments and Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Drug Allergy Treatments and Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Drug Allergy Treatments and Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Drug Allergy Treatments and Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Drug Allergy Treatments and Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Stallergenes Greer Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 84. Stallergenes Greer Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Stallergenes Greer Main Business
Table 86. Stallergenes Greer Latest Developments
Table 87. Allergy Therapeutics Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 89. Allergy Therapeutics Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Allergy Therapeutics Main Business
Table 91. Allergy Therapeutics Latest Developments
Table 92. HAL Allergy Group Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 94. HAL Allergy Group Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. HAL Allergy Group Main Business
Table 96. HAL Allergy Group Latest Developments
Table 97. Circassia Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Circassia Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 99. Circassia Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Circassia Main Business
Table 101. Circassia Latest Developments
Table 102. GlaxoSmithKline plc Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 104. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. GlaxoSmithKline plc Main Business
Table 106. GlaxoSmithKline plc Latest Developments
Table 107. Sunovion Pharmaceuticals Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 109. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Sunovion Pharmaceuticals Main Business
Table 111. Sunovion Pharmaceuticals Latest Developments
Table 112. Teva Pharmaceutical Industries Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 114. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Teva Pharmaceutical Industries Main Business
Table 116. Teva Pharmaceutical Industries Latest Developments
Table 117. Allergan plc Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Allergan plc Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 119. Allergan plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Allergan plc Main Business
Table 121. Allergan plc Latest Developments
Table 122. Mayo Clinic Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 124. Mayo Clinic Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Mayo Clinic Main Business
Table 126. Mayo Clinic Latest Developments
Table 127. AAFA Basic Information, Drug Allergy Treatments and Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. AAFA Drug Allergy Treatments and Drugs Product Portfolios and Specifications
Table 129. AAFA Drug Allergy Treatments and Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. AAFA Main Business
Table 131. AAFA Latest Developments
List of


Figure 1. Picture of Drug Allergy Treatments and Drugs
Figure 2. Drug Allergy Treatments and Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Allergy Treatments and Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Drug Allergy Treatments and Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Drug Allergy Treatments and Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Penicillin and Related Drugs
Figure 10. Product Picture of Sulfa Drugs
Figure 11. Product Picture of Insulin
Figure 12. Product Picture of Iodine
Figure 13. Product Picture of Chemotherapy Drugs
Figure 14. Product Picture of Other
Figure 15. Global Drug Allergy Treatments and Drugs Sales Market Share by Type in 2023
Figure 16. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2019-2024)
Figure 17. Drug Allergy Treatments and Drugs Consumed in Hospitals
Figure 18. Global Drug Allergy Treatments and Drugs Market: Hospitals (2019-2024) & (K Units)
Figure 19. Drug Allergy Treatments and Drugs Consumed in Diagnostic Laboratories
Figure 20. Global Drug Allergy Treatments and Drugs Market: Diagnostic Laboratories (2019-2024) & (K Units)
Figure 21. Drug Allergy Treatments and Drugs Consumed in Research & Academic Laboratories
Figure 22. Global Drug Allergy Treatments and Drugs Market: Research & Academic Laboratories (2019-2024) & (K Units)
Figure 23. Drug Allergy Treatments and Drugs Consumed in Pharmaceutical & Biotechnology Companies
Figure 24. Global Drug Allergy Treatments and Drugs Market: Pharmaceutical & Biotechnology Companies (2019-2024) & (K Units)
Figure 25. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2023)
Figure 26. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application in 2023
Figure 27. Drug Allergy Treatments and Drugs Sales Market by Company in 2023 (K Units)
Figure 28. Global Drug Allergy Treatments and Drugs Sales Market Share by Company in 2023
Figure 29. Drug Allergy Treatments and Drugs Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Drug Allergy Treatments and Drugs Revenue Market Share by Company in 2023
Figure 31. Global Drug Allergy Treatments and Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Drug Allergy Treatments and Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Drug Allergy Treatments and Drugs Sales 2019-2024 (K Units)
Figure 34. Americas Drug Allergy Treatments and Drugs Revenue 2019-2024 ($ Millions)
Figure 35. APAC Drug Allergy Treatments and Drugs Sales 2019-2024 (K Units)
Figure 36. APAC Drug Allergy Treatments and Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Europe Drug Allergy Treatments and Drugs Sales 2019-2024 (K Units)
Figure 38. Europe Drug Allergy Treatments and Drugs Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Drug Allergy Treatments and Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Drug Allergy Treatments and Drugs Revenue 2019-2024 ($ Millions)
Figure 41. Americas Drug Allergy Treatments and Drugs Sales Market Share by Country in 2023
Figure 42. Americas Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2023
Figure 43. Americas Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
Figure 44. Americas Drug Allergy Treatments and Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Drug Allergy Treatments and Drugs Sales Market Share by Region in 2023
Figure 50. APAC Drug Allergy Treatments and Drugs Revenue Market Share by Regions in 2023
Figure 51. APAC Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
Figure 52. APAC Drug Allergy Treatments and Drugs Sales Market Share by Application (2019-2024)
Figure 53. China Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country in 2023
Figure 61. Europe Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2023
Figure 62. Europe Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
Figure 63. Europe Drug Allergy Treatments and Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Drug Allergy Treatments and Drugs Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Drug Allergy Treatments and Drugs Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Drug Allergy Treatments and Drugs Sales Market Share by Application (2019-2024)
Figure 73. Egypt Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Drug Allergy Treatments and Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Drug Allergy Treatments and Drugs in 2023
Figure 79. Manufacturing Process Analysis of Drug Allergy Treatments and Drugs
Figure 80. Industry Chain Structure of Drug Allergy Treatments and Drugs
Figure 81. Channels of Distribution
Figure 82. Global Drug Allergy Treatments and Drugs Sales Market Forecast by Region (2025-2030)
Figure 83. Global Drug Allergy Treatments and Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Drug Allergy Treatments and Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Drug Allergy Treatments and Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Drug Allergy Treatments and Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Drug Allergy Treatments and Drugs Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Drug Allergy Treatments and Drugs Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.